NCT01010425 - Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

May 31, 2010

Conditions

Healthy

Interventions

DRUG

ACP-001 (TransCon PEG hGH)

ACP-001, dose-level 1, s.c., single-dose

DRUG

ACP-001 (TransCon PEG hGH)

ACP-001, dose-level 2, s.c., single-dose

DRUG

ACP-001 (TransCon PEG hGH)

ACP-001, dose-level 3, s.c., single-dose

DRUG

ACP-001 (TransCon PEG hGH)

ACP-001, dose-level 4, s.c., single-dose

DRUG

Placebo

Placebo, s.c., single-dose

DRUG

Human Growth Hormone

Human Growth Hormone, s.c., daily for 7 days

Trial Locations (1)

Toronto